Related Experiment Video
Updated: Jan 13, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Association between Vitamin B12 Levels and Colon Cancer Survival: A Global Network Study
Bruce Chang-Gu1,2, George Golovko2, Anthony P D'Andrea3
1MD-PhD Combined Degree Program, University of Texas Medical Branch John Sealy School of Medicine, Galveston, Texas.
Elevated vitamin B12 levels are linked to worse outcomes in colon cancer patients, including increased metastases and reduced survival. This highlights vitamin B12 as a potential biomarker for colon cancer progression.
Area of Science:
- Oncology
- Biochemistry
- Genetics
Background:
- Emerging research suggests a correlation between elevated vitamin B12 levels and a higher incidence of malignancies.
- Understanding the role of vitamin B12 in colon cancer progression is crucial for identifying new biomarkers and therapeutic targets.
Purpose of the Study:
- To investigate the association between vitamin B12 levels and adverse outcomes in colon cancer patients, specifically focusing on metastases and mortality.
- To explore the relationship between vitamin B12 levels, tumor characteristics, and patient survival.
- To analyze gene expression patterns related to vitamin B12 metabolism in colon cancer.
Main Methods:
- A retrospective analysis of a multi-institutional database (TriNetX) involving 37,106 colon cancer patients with vitamin B12 measurements.
- Patients were stratified into low (<300 pg/mL), normal (300-1000 pg/mL), and elevated (>1000 pg/mL) vitamin B12 groups.
- Statistical analyses included log-rank tests, Cox-proportional hazards models, and risk ratios to compare survival, metastasis incidence, and gene expression from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) projects.
Main Results:
- Elevated vitamin B12 levels were associated with significantly decreased median overall survival (59.4 months) compared to normal (129.8 months) and low (137.3 months) levels.
- Patients with elevated vitamin B12 exhibited higher rates of metastatic involvement, advanced tumor stage at diagnosis, and increased 1-year incidence of liver, lung, and peritoneal metastases.
- Gene expression analysis revealed elevated levels of the vitamin B12-dependent methionine synthase (MTR) in colon cancer tissues, which correlated with poorer survival.
Conclusions:
- Elevated vitamin B12 levels are a significant indicator of adverse outcomes in colon cancer, including increased metastasis and reduced survival.
- The findings suggest that vitamin B12 may serve as a valuable clinical biomarker for predicting colon cancer progression and patient prognosis.
- Further research into the role of MTR in colon cancer pathogenesis could reveal novel therapeutic strategies.
Related Concept Videos
Cancer Survival Analysis
Vitamins
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Cancer Prevention
Some...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Assumptions of Survival Analysis

